These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
285 related items for PubMed ID: 24176397
1. Antiproliferative activities and SAR studies of substituted anthraquinones and 1,4-naphthoquinones. Bhasin D, Etter JP, Chettiar SN, Mok M, Li PK. Bioorg Med Chem Lett; 2013 Dec 15; 23(24):6864-7. PubMed ID: 24176397 [Abstract] [Full Text] [Related]
2. Small-molecule STAT3 signaling pathway modulators from Polygonum cuspidatum. Liu J, Zhang Q, Chen K, Liu J, Kuang S, Chen W, Yu Q. Planta Med; 2012 Sep 15; 78(14):1568-70. PubMed ID: 22855270 [Abstract] [Full Text] [Related]
3. Design, synthesis, and studies of small molecule STAT3 inhibitors. Bhasin D, Cisek K, Pandharkar T, Regan N, Li C, Pandit B, Lin J, Li PK. Bioorg Med Chem Lett; 2008 Jan 01; 18(1):391-5. PubMed ID: 18006313 [Abstract] [Full Text] [Related]
4. Anticancer activity and SAR studies of substituted 1,4-naphthoquinones. Bhasin D, Chettiar SN, Etter JP, Mok M, Li PK. Bioorg Med Chem; 2013 Aug 01; 21(15):4662-9. PubMed ID: 23791367 [Abstract] [Full Text] [Related]
5. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells. Lin L, Hutzen B, Li PK, Ball S, Zuo M, DeAngelis S, Foust E, Sobo M, Friedman L, Bhasin D, Cen L, Li C, Lin J. Neoplasia; 2010 Jan 01; 12(1):39-50. PubMed ID: 20072652 [Abstract] [Full Text] [Related]
6. Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells. Wei CC, Ball S, Lin L, Liu A, Fuchs JR, Li PK, Li C, Lin J. Int J Oncol; 2011 Jan 01; 38(1):279-85. PubMed ID: 21109950 [Abstract] [Full Text] [Related]
10. Synthesis, characterization and antiproliferative activity of 1,2-naphthoquinone and its derivatives. Shukla S, Srivastava RS, Shrivastava SK, Sodhi A, Kumar P. Appl Biochem Biotechnol; 2012 Jul 01; 167(5):1430-45. PubMed ID: 22258648 [Abstract] [Full Text] [Related]
11. Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain. Qiu HY, Zhu X, Luo YL, Lin HY, Tang CY, Qi JL, Pang YJ, Yang RW, Lu GH, Wang XM, Yang YH. Sci Rep; 2017 Jun 06; 7(1):2863. PubMed ID: 28588262 [Abstract] [Full Text] [Related]
12. Design, synthesis and biological evaluation of novel plumbagin derivatives as potent antitumor agents with STAT3 inhibition. Li N, Ou J, Bao N, Chen C, Shi Z, Chen L, Sun J. Bioorg Chem; 2020 Nov 06; 104():104208. PubMed ID: 32919131 [Abstract] [Full Text] [Related]